⌘K

Login Start Free

Home/Filings/4/0001628280-25-014191

4//SEC Filing

Coste Catherine 4

Accession 0001628280-25-014191

CIK 0000834365other

View on SEC.gov Company Profile

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 7:09 PM ET

Size

4.9 KB

Accession

0001628280-25-014191

Insider Transaction Report

Form 4

Period: 2025-03-18

BIOLIFE SOLUTIONS INCBLFS

Coste Catherine

Director

Transactions

Award
Common Stock
2025-03-18+5,701→ 5,701 total

Footnotes (1)

[F1]The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the measurement date of 01-02-2025.

Documents

1 file

4
wk-form4_1742512161.xmlPrimary
FORM 4

Issuer

BIOLIFE SOLUTIONS INC

CIK 0000834365

Entity typeother

Related Parties

1

filerCIK 0001821432

Filing Metadata

Form type: 4
Filed: Mar 19, 8:00 PM ET
Accepted: Mar 20, 7:09 PM ET
Size: 4.9 KB

View on SEC.gov